Market Tracker

12/05 11:37am ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.35
Delayed Data
As of 11:13am ET
 +0.04 / +3.05%
Today’s Change
1.15
Today|||52-Week Range
2.28
-30.41%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.31
Today’s open1.30
Day’s range1.29 - 1.35
Volume9,189
Average volume (3 months)59,099
Market cap$50.6M
Dividend yield--
Data as of 11:13am ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
OCRXOcera Therapeutics I...+0.05+2.27%
ADHDAlcobra Ltd+0.04+2.14%
ITUSITUS Corp-0.02-0.36%
APDNApplied DNA Sciences...+0.02+1.11%
Data as of 11:21am ET, 12/05/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts